COO vs DAWN · P/E 36, rev $4.09B vs rev $131.2M
The Cooper Companies, Inc (COO) versus Day One Biopharmaceuticals Inc (DAWN) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
COO currently screens at market cap $14.92B and trailing P/E 36.1. DAWN currently screens at market cap $656.8M.
Not investment advice. Open the COO and DAWN stock pages for the full models.
Not investment advice.